| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 309.068 | 376.360 | 429.165 | 490.449 |
| Total Income - EUR | - | - | - | - | - | - | 316.798 | 379.454 | 437.259 | 504.894 |
| Total Expenses - EUR | - | - | - | - | - | - | 153.635 | 209.918 | 312.743 | 362.040 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 163.163 | 169.536 | 124.516 | 142.854 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 160.302 | 166.162 | 121.361 | 128.317 |
| Employees | - | - | - | - | - | - | 4 | 4 | 5 | 6 |
Check the financial reports for the company - Dental Endorphine S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 25.207 | 55.649 | 107.441 | 411.834 |
| Current Assets | - | - | - | - | - | - | 144.137 | 117.958 | 161.268 | 102.987 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 62.001 | 6.958 | 4.210 |
| Cash | - | - | - | - | - | - | 144.137 | 55.957 | 154.310 | 98.777 |
| Shareholders Funds | - | - | - | - | - | - | 160.343 | 166.359 | 220.997 | 250.477 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 9.001 | 7.248 | 10.490 | 237.286 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 37.222 | 27.058 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dental Endorphine S.r.l.